![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 26, 24698-24705, July 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104
Raf-1 protects cells from apoptosis, independently of its signals to MEK and ERK, by translocating to the mitochondria where it binds Bcl-2 and displaces BAD. However, the answer to the question of how Raf-1 is normally lured to the mitochondria and becomes activated remains elusive. p21-activated protein kinases (Paks) are serine/threonine protein kinases that phosphorylate Raf-1 at Ser-338 and Ser-339. Here we elucidate the molecular mechanism through which Pak1 signals to BAD through a Raf-1-activated pathway. Upon phosphorylation by Pak1, Raf-1 translocates to mitochondria and phosphorylates BAD at Ser-112. Moreover, the mitochondrial translocation of Raf-1 and the interaction between Raf-1 and Bcl-2 are regulated by Raf-1 phosphorylation at Ser-338/Ser-339. Notably, we show that formation of a Raf-1-Bcl-2 complex coincides with loss of an interaction between Bcl-2 and BAD. These signals are specific for Pak1, because Src-activated Raf-1 only stimulates the MAP kinase cascade. Thus, our data identify the molecular connections of a Pak1-Raf-1-BAD pathway that is involved in cell survival signaling.
Received for publication, November 29, 2004 , and in revised form, April 21, 2005.
* This work was supported by National Institutes of Health Grant GM48241 and the Department of Defense Neurofibromatosis Program Grant DAMD17-01-1-07190. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology, University of Pennsylvania School of Medicine, 3620 Hamilton Walk, Philadelphia, PA 19104. Tel.: 215-898-1912; Fax: 215-573-2236; E-mail: field{at}pharm.med.upenn.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Galmiche, J. Fueller, A. Santel, G. Krohne, I. Wittig, A. Doye, M. Rolando, G. Flatau, E. Lemichez, and U. R. Rapp Isoform-specific Interaction of C-RAF with Mitochondria J. Biol. Chem., May 23, 2008; 283(21): 14857 - 14866. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. U. Alejandro and J. D. Johnson Inhibition of Raf-1 Alters Multiple Downstream Pathways to Induce Pancreatic -Cell Apoptosis J. Biol. Chem., January 25, 2008; 283(4): 2407 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Mayhew, E. D. Jeffery, N. E. Sherman, K. Nelson, J. M. Polefrone, S. J. Pratt, J. Shabanowitz, J. T. Parsons, J. W. Fox, D. F. Hunt, et al. Identification of phosphorylation sites in betaPIX and PAK1 J. Cell Sci., November 15, 2007; 120(22): 3911 - 3918. [Full Text] [PDF] |
||||
![]() |
S. Kebache, J. Ash, M. G. Annis, J. Hagan, M. Huber, J. Hassard, C. L. Stewart, M. Whiteway, and A. Nantel Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival J. Biol. Chem., July 27, 2007; 282(30): 21873 - 21883. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. E. E. Rennefahrt, S. W. Deacon, S. A. Parker, K. Devarajan, A. Beeser, J. Chernoff, S. Knapp, B. E. Turk, and J. R. Peterson Specificity Profiling of Pak Kinases Allows Identification of Novel Phosphorylation Sites J. Biol. Chem., May 25, 2007; 282(21): 15667 - 15678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Alavi, L. Acevedo, W. Min, and D. A. Cheresh Chemoresistance of Endothelial Cells Induced by Basic Fibroblast Growth Factor Depends on Raf-1-Mediated Inhibition of the Proapoptotic Kinase, ASK1 Cancer Res., March 15, 2007; 67(6): 2766 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hekman, S. Albert, A. Galmiche, U. E. E. Rennefahrt, J. Fueller, A. Fischer, D. Puehringer, S. Wiese, and U. R. Rapp Reversible Membrane Interaction of BAD Requires two C-terminal Lipid Binding Domains in Conjunction with 14-3-3 Protein Binding J. Biol. Chem., June 23, 2006; 281(25): 17321 - 17336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahaus, N. Desloges, and M. H. Wolff Varicella-zoster virus influences the activities of components and targets of the ERK signalling pathway. J. Gen. Virol., April 1, 2006; 87(Pt 4): 749 - 758. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |